ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

Animal Core

Active
Institution
WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC
Principal investigator
Christopher Michael Peters
Funding
$432K
Duration
2022–2027
Open portfolio

Moonbase score

Still being scored

Abstract

The Animal Core will provide essential services and facilities to the preclinical projects in a standardized and efficient manner, utilizing shared facilities, equipment, and personnel in a coordinated fashion. The services to be provided to each preclinical project are divided into three specific aims. Dr. Christopher Peters will oversee the Animal Core and will meet with monthly or as needed with Drs. Boada, Martin, Romero-Sandoval to assure that the Core efficiently performs these three key functions. Dr. Peters will provide oversight for regulatory affairs within the Program regarding animal use including approval and compliance with protocols for the IACUC and Biohazard Safety Committee. Specific Aim 1 is to provide standardized in vivo surgical and behavioral procedures in animals utilized by preclinical projects. Both projects involving animals require animal procurement and identification, surgical preparation and behavioral assessment of sensory and affective pain related outcomes. Specific Aim 2 will provide standardized methods for collection of plasma and brain tissue and sample preparation for determination of oxytocin levels as part of PK/PD studies. We will standardize immunohistochemical approaches across preclinical projects for verification of viral mediated protein expression in discrete populations of neurons in brain or spinal cord tissue. These services include sacrifice and transcardial perfusion with paraformaldehyde, tissue harvest, cryoprotection and cryosectioning, immunohistochemistry, and fluorescent microscopy including data collection and analysis Specific Aim 3 will provide for generation of and maintenance of a novel transgenic oxytocin-cre rat colony. Dr. Romero-Sandoval will assist with colony management, breeding and genotyping to ensure sufficient animals are available in a timely manner for preclinical studies in Project 2. These essential functions will standardize and coordinate services and procedures throughout the Program and provide an efficient and costeffective structure for collaboration.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEP01ZNS1-SRB-Kstandardizepreclinicalanimalcolonystandardizedanimalsspecific aimaim provide

Questions for WAKE FOREST UNIVERSITY HEALTH SCIENCES

Answered by the team behind this research.

Same institution, same topic, scored first.